Search results
Psoriasis and Depression: What’s the Connection?
Verywell Health via Yahoo News· 5 days agoPsoriasis is a chronic skin condition that can affect your mood, and many people with psoriasis experience depression. Here’s what you can do if you feel...
Siliq and cost: Reducing long-term drug costs and more
Medical News Today· 1 day agoSiliq (brodalumab) is a brand-name subcutaneous injection prescribed for plaque psoriasis in adults...
Experts Share How to Do a Hot Oil Treatment for Hair at Home
Prevention via Yahoo News· 5 days agoIt can also just... feel nice. Boost blood flow to scalp You may have heard that hot oil treatments...
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 3 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent ...
Amgen (AMGN) Scheduled to Post Earnings on Thursday
ETF DAILY NEWS· 5 days agoAmgen (NASDAQ:AMGN – Get Free Report) is set to announce its earnings results after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of $3.82 per share ...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 2 days agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 1 day agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic...
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 5 days agoA decision on approval is expected in the fourth quarter of 2024.
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 3 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
FOX 59 Indianapolis· 6 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
